- Home
- AQST vs EAD Comparison
AQST vs EAD Comparison
Compare AQST & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- EAD
- Stock Information
- Founded
- AQST 2004
- EAD 2003
- Country
- AQST United States
- EAD United States
- Employees
- AQST N/A
- EAD N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- EAD Finance/Investors Services
- Sector
- AQST Health Care
- EAD Finance
- Exchange
- AQST Nasdaq
- EAD Nasdaq
- Market Cap
- AQST 390.4M
- EAD 416.0M
- IPO Year
- AQST 2018
- EAD N/A
- Fundamental
- Price
- AQST $3.77
- EAD $7.11
- Analyst Decision
- AQST Strong Buy
- EAD
- Analyst Count
- AQST 6
- EAD 0
- Target Price
- AQST $10.67
- EAD N/A
- AVG Volume (30 Days)
- AQST 1.4M
- EAD 178.9K
- Earning Date
- AQST 08-11-2025
- EAD 01-01-0001
- Dividend Yield
- AQST N/A
- EAD 8.91%
- EPS Growth
- AQST N/A
- EAD N/A
- EPS
- AQST N/A
- EAD N/A
- Revenue
- AQST $44,132,000.00
- EAD N/A
- Revenue This Year
- AQST N/A
- EAD N/A
- Revenue Next Year
- AQST $38.71
- EAD N/A
- P/E Ratio
- AQST N/A
- EAD N/A
- Revenue Growth
- AQST N/A
- EAD N/A
- 52 Week Low
- AQST $2.12
- EAD $5.69
- 52 Week High
- AQST $5.80
- EAD $6.81
- Technical
- Relative Strength Index (RSI)
- AQST 44.00
- EAD 59.33
- Support Level
- AQST $3.85
- EAD $6.99
- Resistance Level
- AQST $4.13
- EAD $7.07
- Average True Range (ATR)
- AQST 0.25
- EAD 0.04
- MACD
- AQST -0.03
- EAD 0.00
- Stochastic Oscillator
- AQST 13.79
- EAD 97.56
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.